1. Home
  2. News
  3. InnoCare Pharma Ltd.
  4. Semi-annual Report in 2024
More InnoCare Pharma Ltd. news
InnoCare Pharma Ltd.SSE: 688428

Semi-annual Report in 2024

Aug 21, 2024 · Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 21, 2024 · 199 pages · Chinese

On 6ix: 6ix.com/news/semi-annual-report-in-2024-81

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

  • Announcement on Convening the 2024 Semi-Annual Performance BriefingAug 14, 2024
  • Announcement on Voluntary Disclosure of Completing the 1st Administration of ICP-332 in Patients in the United StatesJul 25, 2024
  • Indicative Announcement on Change in Equity of Shareholder with Over 5% SharesJul 20, 2024
  • Announcement on the "Corporate Value and Return Enhancement" Action Plan 2024Jul 18, 2024

Later from InnoCare Pharma

  • Announcement on Voluntary Disclosure of Clinical Trial Progress of AobrutinibSep 9, 2024
  • Announcement on Listing and Circulation of Initial Public Offering of Strategic Placement Restricted SharesSep 11, 2024
  • Announcement on Change of Sponsor Representative for Continuous SupervisionSep 21, 2024
  • Announcement on the Resignation of Non-executive Directors and Independent Non-executive Directors and the Change of Members of Special Committees of the Board of DirectorsSep 26, 2024
  • Announcement on Voluntary Disclosure of Phase II Clinical Trial Result of ICP-488Oct 10, 2024
All InnoCare Pharma news releases↗

Follow InnoCare Pharma into a list and get an email when it puts out news.

Follow InnoCare Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer